Current concepts on the surgical and medical management of osteosarcoma
暂无分享,去创建一个
[1] H. Weinberg,et al. The Role of Microvascular Surgery in Limb‐Sparing Procedures for Malignant Tumors of the Knee , 1993, Plastic and reconstructive surgery.
[2] S. Amin,et al. Limb salvage management of pathologic fractures of primary malignant bone tumors. , 2005, Cancer control : journal of the Moffitt Cancer Center.
[3] W. Enneking,et al. The effect of inadvertent tumor contamination of wounds during the surgical resection of musculoskeletal neoplasms , 1988, Cancer.
[4] W. Winkelmann,et al. Limb Salvage and Outcome of Osteosarcoma , 1999 .
[5] M. Gebhardt,et al. The use of bone allografts for limb salvage in high-grade extremity osteosarcoma. , 1991, Clinical orthopaedics and related research.
[6] T. Ngoma. World Health Organization cancer priorities in developing countries. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] G. Rosen,et al. Endoprosthetic replacement for stage IIB osteosarcoma. , 1991, Clinical orthopaedics and related research.
[8] S R Cannon,et al. Non-invasive distal femoral expandable endoprosthesis for limb-salvage surgery in paediatric tumours. , 2006, The Journal of bone and joint surgery. British volume.
[9] L. B. Kagen. Use of denial in adolescents with bone cancer. , 1976, Health & social work.
[10] E. Venkatraman,et al. Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] R. Wilkins,et al. The Phenix Expandable Prosthesis: Early American Experience , 2001, Clinical orthopaedics and related research.
[12] Kazutaka Kikuta,et al. Global Protein-expression Analysis of Bone and Soft Tissue Sarcomas , 2008, Clinical orthopaedics and related research.
[13] A. Sudo,et al. Limb salvage for bone sarcoma of the proximal tibia , 1992, International Orthopaedics.
[14] M. Link,et al. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] Toshifumi Ozaki,et al. Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Holland,et al. Doxorubicin in Disseminated , 1972 .
[17] J. Armitage. Emerging Applications of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor , 1998 .
[18] K. Starling,et al. Cis-diamminedichloroplatinum (NSC-119875) in childhood malignancies: a Southwest Oncology Group study. , 1978, Medical and pediatric oncology.
[19] Toshihiko Yamashita,et al. ErbB2 expression is correlated with increased survival of patients with osteosarcoma , 2002, Cancer.
[20] R. Jove,et al. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival. , 2007, Cancer research.
[21] G. Blunn,et al. Stanmore non-invasive growing arthrodesis endoprosthesis in the reconstruction of complicated total knee arthroplasty: A case report. , 2006, The Knee.
[22] J. Shuster,et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. , 1986, The New England journal of medicine.
[23] J. Sloan,et al. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[24] T. Giordano,et al. Absence of HER2/neu gene expression in osteosarcoma and skeletal Ewing's sarcoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[25] A. Formann,et al. Quality of life and psychosocial adjustment of young patients after treatment of bone cancer , 1998, Cancer.
[26] Mike Wilson,et al. IGF‐1 receptor contributes to the malignant phenotype in human and canine osteosarcoma , 2004, Journal of cellular biochemistry.
[27] M. Campanacci,et al. Local recurrence after amputation for osteosarcoma. , 1980, The Journal of bone and joint surgery. British volume.
[28] Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma , 2005, British Journal of Cancer.
[29] H. Mankin,et al. Osteoarticular and intercalary allograft transplantation in the management of malignant tumors of bone , 1982, Cancer.
[30] R. Grimer,et al. Endoprosthetic reconstruction for the treatment of musculoskeletal tumors of the appendicular skeleton and pelvis. , 2008, The Journal of bone and joint surgery. American volume.
[31] M. Varini,et al. High-dose ifosfamide in advanced osteosarcoma. , 1985, Cancer treatment reports.
[32] J. Shuster,et al. Adjuvant chemotherapy of high-grade osteosarcoma of the extremity. Updated results of the Multi-Institutional Osteosarcoma Study. , 1991, Clinical orthopaedics and related research.
[33] M. J. van de Vijver,et al. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas. , 2004, European journal of cancer.
[34] R. Marcove,et al. Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative cases. , 1970, The Journal of bone and joint surgery. American volume.
[35] G COOPER,et al. Bone cancer. , 1951, Virginia medical monthly.
[36] H. Mankin,et al. Osteoarticular allografts for reconstruction after resection of a musculoskeletal tumor in the proximal end of the tibia. , 1994, The Journal of bone and joint surgery. American volume.
[37] E. Kleinerman,et al. Aerosol gemcitabine inhibits the growth of primary osteosarcoma and osteosarcoma lung metastases , 2005, International journal of cancer.
[38] J. Holland,et al. Doxorubicin in disseminated osteosarcoma. , 1972, JAMA.
[39] K. Katz,et al. Prognostic factors in non-metastatic limb osteosarcoma: A 20-year experience of one center. , 1999, International journal of oncology.
[40] T. Delaney,et al. Radiotherapy for local control of osteosarcoma. , 2003, International journal of radiation oncology, biology, physics.
[41] H. Strander,et al. Effect of human leukocyte interferon on the growth of human osteosarcoma cells in tissue culture , 1977, International journal of cancer.
[42] B. Fuchs,et al. Pemetrexed, a multitargeted antifolate drug, demonstrates lower efficacy in comparison to methotrexate against osteosarcoma cell lines , 2008, Pediatric blood & cancer.
[43] S. Ferrari,et al. Local and systemic control for osteosarcoma of the extremity treated with neoadjuvant chemotherapy and limb salvage surgery: the Rizzoli experience. , 2000, Oncology reports.
[44] M. Malawer,et al. Constrained Total Scapula Reconstruction After Resection of a High-Grade Sarcoma , 2002, Clinical orthopaedics and related research.
[45] D. Morton,et al. Immunologic studies of human sarcomas: Additional evidence suggesting an associated sarcoma virus , 1970, Cancer.
[46] M. Bernstein,et al. Cyclophosphamide plus topotecan in children with recurrent or refractory solid tumors: a Pediatric Oncology Group phase II study. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] P. Adamson,et al. Topotecan by 21‐day continuous infusion in children with relapsed or refractory solid tumors: A Children's Oncology Group study , 2006, Pediatric blood & cancer.
[48] L. Fritz,et al. A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors , 2003, Nature.
[49] A. Minami,et al. Simultaneous reconstruction of bone and skin defects by free fibular graft with a skin flap , 1986, Microsurgery.
[50] H. Strander. Interferons and osteosarcoma. , 2007, Cytokine & growth factor reviews.
[51] N. Jaffe,et al. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? , 2002, Cancer.
[52] N. Jaffe,et al. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. , 1974, The New England journal of medicine.
[53] C. A. Kuntz,et al. Improved Survival Associated With Postoperative Wound Infection in Dogs Treated With Limb-Salvage Surgery for Osteosarcoma , 2005, Annals of Surgical Oncology.
[54] H. Strander,et al. Influence of Human α-Interferon on Four Human Osteosarcoma Xenografts in Nude Mice , 1985 .
[55] J. Dubousset,et al. [Vascularized peroneal reconstruction after bloc resection of tumors or congenital malformations of the upper limb in children]. , 2000, Bulletin de l'Academie nationale de medecine.
[56] L. Helman,et al. Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma. , 2005, Cancer research.
[57] S. Ferrari,et al. Local recurrence and local control of non‐metastatic osteosarcoma of the extremities: A 27‐year experience in a single institution , 2007, Journal of surgical oncology.
[58] E. Madon,et al. Osteosarcoma cell line growth inhibition by zoledronate-stimulated effector cells. , 2007, Cellular immunology.
[59] N. Jaffe,et al. Concomitant presence of tumor-specific cytotoxic and inhibitor lymphocytes in patients with osteogenic sarcoma. , 1977, The New England journal of medicine.
[60] E. Pignotti,et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. , 2002, The Journal of bone and joint surgery. British volume.
[61] Haroon-ur-Rasheed,et al. Autoclaved Tumor Bone for Reconstruction: An Alternative in Developing Countries , 2006, Clinical orthopaedics and related research.
[62] S. Carter,et al. The therapy of osteogenic sarcoma: Current status and thoughts for the future , 1972, Journal of surgical oncology.
[63] S. McCarthy,et al. En-bloc resection, extracorporeal irradiation, and re-implantation in limb salvage for bony malignancies. , 2005, The Journal of bone and joint surgery. British volume.
[64] M. Heymann,et al. Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma‐bearing mice , 2005, Cancer.
[65] S. Scully,et al. Direct tendon attachment and healing to porous tantalum: an experimental animal study. , 2007, The Journal of bone and joint surgery. American volume.
[66] M. Semik,et al. Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[67] J. Armitage. Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor. , 1998, Blood.
[68] A. Huvos,et al. Expression of HER2/erbB-2 correlates with survival in osteosarcoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[69] H. Horiuchi,et al. ErbB‐2 expression is correlated with poor prognosis for patients with osteosarcoma , 1996, Cancer.
[70] R. Kumar,et al. GM‐CSF‐transduced B16 melanoma cells are highly susceptible to lysis by normal murine macrophages and poorly tumorigenic in immune‐compromised mice , 1999, Journal of leukocyte biology.
[71] W. Enneking,et al. A System for the Surgical Staging of Musculoskeletal Sarcoma , 1980, Clinical orthopaedics and related research.
[72] L. Helman,et al. Inhibition of the CXCR4/CXCL12 chemokine pathway reduces the development of murine pulmonary metastases , 2007, Clinical & Experimental Metastasis.
[73] M. Gebhardt,et al. Survival Data for 648 Patients with Osteosarcoma Treated at One Institution , 2004, Clinical orthopaedics and related research.
[74] Paul A Meyers,et al. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[75] P. Lin,et al. Endoprosthetic and Allograft-prosthetic Composite Reconstruction of the Proximal Femur for Bone Neoplasms , 2006, Clinical orthopaedics and related research.
[76] D. Ludwig,et al. IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor , 2007, Clinical Cancer Research.
[77] V. Sondak,et al. Laboratory and clinical evidence of synergistic cytotoxicity of sequential treatment with gemcitabine followed by docetaxel in the treatment of sarcoma. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[78] P. Manley,et al. Therapy for osteosarcoma in dogs with intravenous injection of liposome-encapsulated muramyl tripeptide. , 1989, Journal of the National Cancer Institute.
[79] H J Mankin,et al. Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femur. , 2005, The Journal of bone and joint surgery. American volume.
[80] P. Ravdin,et al. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review. , 1995, Gene.
[81] J. Squire,et al. HER2 Amplification and Overexpression Is Not Present in Pediatric Osteosarcoma: A Tissue Microarray Study , 2005, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[82] W. Ebell,et al. Neoadjuvant chemotherapy for osteogenic sarcoma: results of a Cooperative German/Austrian study. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] 松山 茂生. Induced Proliferation of Human Osteosarcoma Cells β SB-431542 and Gleevec Inhibit Transforming Growth Factor-Updated , 2003 .
[84] P. Anderson,et al. Gemcitabine Radiosensitization after High-Dose Samarium for Osteoblastic Osteosarcoma , 2005, Clinical Cancer Research.
[85] John Healey,et al. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma , 2007, Cancer.
[86] H. Strander,et al. Interferon-α as the only adjuvant treatment in high-grade osteosarcoma: Long term results of the Karolinska Hospital series , 2005, Acta oncologica.
[87] W. Winkelmann,et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[88] M. Agarwal,et al. Limb Salvage Surgery for Osteosarcoma: Effective Low-cost Treatment , 2007, Clinical orthopaedics and related research.
[89] P. Anderson. Effectiveness of radiotherapy for osteosarcoma that responds to chemotherapy. , 2003, Mayo Clinic proceedings.
[90] Frcs L. M. Jeys MSc,et al. Post Operative Infection and Increased Survival in Osteosarcoma Patients: Are They Associated? , 2007, Annals of Surgical Oncology.
[91] H. Kindler. The pemetrexed/gemcitabine combination in pancreatic cancer , 2002, Cancer.
[92] W. Enneking,et al. The Effect of Contaminated Surgical Margins Revisited , 2002, Clinical orthopaedics and related research.
[93] E. Mackenzie,et al. Limb Amputation and Limb Deficiency: Epidemiology and Recent Trends in the United States , 2002, Southern medical journal.
[94] E. Kleinerman,et al. Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[95] W. Winkelmann,et al. Limb salvage and outcome of osteosarcoma. The University of Muenster experience. , 1999, Clinical orthopaedics and related research.
[96] E. Jaffee,et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[97] H. S. Nicholson,et al. Late effects of therapy in survivors of childhood and adolescent osteosarcoma. , 1993, Cancer treatment and research.